Dupont Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-47,941
| Closed | -$140K | – | 1562 |
|
|
2020
Q2 | $140K | Sell |
47,941
-33,821
| -41% | -$98.8K | ﹤0.01% | 1214 |
|
|
2020
Q1 | $231K | Sell |
81,762
-156,417
| -66% | -$442K | 0.01% | 969 |
|
|
2019
Q4 | $773K | Sell |
238,179
-41,378
| -15% | -$134K | 0.02% | 665 |
|
|
2019
Q3 | $604K | Sell |
279,557
-29,969
| -10% | -$64.8K | 0.01% | 706 |
|
|
2019
Q2 | $972K | Hold |
309,526
| – | – | 0.02% | 557 |
|
|
2019
Q1 | $1.15M | Buy |
309,526
+109,978
| +55% | +$409K | 0.03% | 507 |
|
|
2018
Q4 | $579K | Buy |
+199,548
| New | +$579K | 0.01% | 684 |
|
|
2014
Q2 | – | Sell |
-87,194
| Closed | -$725K | – | 725 |
|
|
2014
Q1 | $725K | Sell |
87,194
-51,170
| -37% | -$425K | 0.01% | 553 |
|
|
2013
Q4 | $1.17M | Sell |
138,364
-206,857
| -60% | -$1.75M | 0.02% | 480 |
|
|
2013
Q3 | $2.75M | Sell |
345,221
-110,310
| -24% | -$879K | 0.05% | 302 |
|
|
2013
Q2 | $3.52M | Buy |
+455,531
| New | +$3.52M | 0.07% | 260 |
|